| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
1989-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1993-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-162400-B1 |
| titleOfInvention |
A method of producing a transdermal therapeutic system PL |
| abstract |
A composition for transdermal administration is characterised in that it contains gestodene where appropriate in combination with one or two oestrogen(s). |
| priorityDate |
1989-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |